We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$27.7B
AUM Growth
-$246M
Cap. Flow
-$2B
Cap. Flow %
-7.2%
Top 10 Hldgs %
13.52%
Holding
662
New
92
Increased
165
Reduced
228
Closed
126

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$137M
2
ALGN icon
Align Technology
ALGN
+$126M
3
META icon
Meta Platforms (Facebook)
META
+$112M
4
LRCX icon
Lam Research
LRCX
+$101M
5
TSM icon
TSMC
TSM
+$98.6M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$238M
2
DE icon
Deere & Co
DE
+$150M
3
LLY icon
Eli Lilly
LLY
+$148M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$125M
5
ENPH icon
Enphase Energy
ENPH
+$118M

Sector Composition

Rank Sector Weight
1 Technology 23.41%
2 Healthcare 14.8%
3 Financials 12.96%
4 Industrials 12.62%
5 Consumer Discretionary 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTY icon
451
Century Casinos
CNTY
$34M
$723K ﹤0.01%
98,600
ISRG icon
452
Intuitive Surgical
ISRG
$127B
$625K ﹤0.01%
2,446
-350,556
-99% -$86.4M
EVR icon
453
Evercore
EVR
$12.4B
$609K ﹤0.01%
5,274
-155,286
-97% -$19.3M
AME icon
454
Ametek
AME
$55.4B
$512K ﹤0.01%
3,528
-476,587
-99% -$67.7M
PTVE
455
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$436K ﹤0.01%
54,555
-453,293
-89% -$4.66M
GILD icon
456
Gilead Sciences
GILD
$162B
$433K ﹤0.01%
5,220
+10
+0.2% +$828
NUVA
457
DELISTED
NuVasive, Inc.
NUVA
$354K ﹤0.01%
8,573
MRK icon
458
Merck
MRK
$322B
$239K ﹤0.01%
2,242
-681
-23% -$73.5K
SBDS
459
DELISTED
Solo Brands Inc
SBDS
$138K ﹤0.01%
+480
New +$92.3K
A icon
460
Agilent Technologies
A
$39.1B
-42,203
Closed -$6.32M
ADM icon
461
Archer Daniels Midland
ADM
$38.2B
-274,357
Closed -$25.5M
AES icon
462
AES
AES
$10.5B
-9,000
Closed -$259K
AGCO icon
463
AGCO
AGCO
$7.15B
-63,331
Closed -$8.78M
AIP icon
464
Arteris
AIP
$1.38B
-480,841
Closed -$2.07M
AKYA
465
DELISTED
Akoya BioSciences
AKYA
-284,946
Closed -$2.73M
ALNY icon
466
Alnylam Pharmaceuticals
ALNY
$27.5B
-523,972
Closed -$125M
AMGN icon
467
Amgen
AMGN
$208B
-85,250
Closed -$22.4M
AMRC icon
468
Ameresco
AMRC
$1.12B
-811,226
Closed -$46.4M
AQN icon
469
Algonquin Power & Utilities
AQN
$4.49B
-173,500
Closed -$1.13M
AR icon
470
Antero Resources
AR
$11.1B
-71,451
Closed -$2.21M
ARRY icon
471
Array Technologies
ARRY
$803M
-1,772,368
Closed -$34.3M
BABA icon
472
Alibaba
BABA
$293B
-510,396
Closed -$45M
BF.B icon
473
Brown-Forman Class B
BF.B
$13.2B
-352,000
Closed -$23.1M
BIIB icon
474
Biogen
BIIB
$30B
-264,315
Closed -$73.2M
BILI icon
475
Bilibili
BILI
$7.99B
-1,700,000
Closed -$40.3M

Similar funds

Lord, Abbett & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Lord, Abbett & Co held 662 positions worth $27.7B, down 0.88% from $28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Lord, Abbett & Co withdrew a net $2B in Q1 2023, closing 126 positions and reducing 228 holdings. Its most notable exit was Deere & Co, an estimated $150M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lord, Abbett & Co opened a new position in Align Technology worth $142M.

  • Lord, Abbett & Co's largest Q1 2023 buy was Align Technology: 426,010 shares worth $142M.
  • Lord, Abbett & Co added most to NVIDIA in Q1 2023, an estimated $137M increase.
  • Lord, Abbett & Co's biggest Q1 2023 reduction was Microsoft, cutting an estimated $238M.
  • Lord, Abbett & Co fully exited Deere & Co in Q1 2023, selling an estimated $150M.
  • Lord, Abbett & Co's ten largest holdings make up 14% of its $27.7B portfolio in Q1 2023.
  • Lord, Abbett & Co opened 92 new positions and closed 126 in Q1 2023.
  • Lord, Abbett & Co's portfolio value fell 0.88% quarter-over-quarter to $27.7B.

Based on Lord, Abbett & Co's 13F filing for Q1 2023, filed 12 May 2023.